<DOC>
	<DOC>NCT00092391</DOC>
	<brief_summary>The purpose of this study is to determine the mumps virus strength at the end of shelf-life (expiration date) of an approved vaccine.</brief_summary>
	<brief_title>A Study of An Approved Vaccine at Mumps Expiry Potency in Healthy Children 12 to 18 Months of Age (V205C-007)(COMPLETED)</brief_title>
	<detailed_description />
	<mesh_term>Rubella</mesh_term>
	<mesh_term>Mumps</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Healthy children 12 to 18 months of age History or prior exposure to measles, mumps, rubella or varicella History of anaphylactoid reactions or hypersensitivity to any component of the vaccine, including gelatin and neomycin</criteria>
	<gender>All</gender>
	<minimum_age>12 Months</minimum_age>
	<maximum_age>18 Months</maximum_age>
	<verification_date>October 2015</verification_date>
</DOC>